Timeline

Rita Azevedo
Research Engineer
09 Apr 2022
publication

Mass Spectrometry for Neurobiomarker Discovery: The Relevance of Post-Translational Modifications.

Read more
01 Jan 2022
publication

Glycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion.

Read more
09 Jun 2021
publication

Glycoproteomics identifies HOMER3 as a potentially targetable biomarker triggered by hypoxia and glucose deprivation in bladder cancer.

Read more
07 Feb 2021
publication

Target Score-A Proteomics Data Selection Tool Applied to Esophageal Cancer Identifies GLUT1-Sialyl Tn Glycoforms as Biomarkers of Cancer Aggressiveness.

Read more
02 Apr 2020
publication

Nucleolin-Sle A Glycoforms as E-Selectin Ligands and Potentially Targetable Biomarkers at the Cell Surface of Gastric Cancer Cells.

Read more
25 Mar 2019
publication

Exploring sialyl-Tn expression in microfluidic-isolated circulating tumour cells: A novel biomarker and an analytical tool for precision oncology applications.

Read more
01 Jan 2019
publication

Protein Glycosylation and Tumor Microenvironment Alterations Driving Cancer Hallmarks.

Read more
01 Jul 2018
publication

Glycan affinity magnetic nanoplatforms for urinary glycobiomarkers discovery in bladder cancer.

Read more
01 May 2018
publication

Circulating tumor cells in bladder cancer: Emerging technologies and clinical implications foreseeing precision oncology.

Read more
16 Jan 2018
publication

In silico approaches for unveiling novel glycobiomarkers in cancer.

Read more
01 Jan 2018
publication

CD44 glycoprotein in cancer: a molecular conundrum hampering clinical applications.

Read more
01 Dec 2017
publication

Sialyl-Tn identifies muscle-invasive bladder cancer basal and luminal subtypes facing decreased survival, being expressed by circulating tumor cells and metastases.

Read more
31 Oct 2017
publication

Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology?

Read more
01 Aug 2017
publication

Targeted O-glycoproteomics explored increased sialylation and identified MUC16 as a poor prognosis biomarker in advanced-stage bladder tumours.

Read more
01 Oct 2016
publication

Moving toward personalized medicine in rheumatoid arthritis: SNPs in methotrexate intracellular pathways are associated with methotrexate therapeutic outcome.

Read more
27 Sep 2016
publication

Hypoxia enhances the malignant nature of bladder cancer cells and concomitantly antagonizes protein O-glycosylation extension.

Read more
01 Oct 2015
publication

Smartphone application for rheumatoid arthritis self-management: cross-sectional study revealed the usefulness, willingness to use and patients’ needs.

Read more
28 Sep 2015
publication

Emerging antibody-based therapeutic strategies for bladder cancer: A systematic review.

Read more
16 Jun 2015
publication

Pharmacogenomics of Methotrexate Membrane Transport Pathway: Can Clinical Response to Methotrexate in Rheumatoid Arthritis Be Predicted?

Read more
01 Mar 2015
publication

Future perspectives of Smartphone applications for rheumatic diseases self-management.

Read more
01 Nov 2014
publication

SLC19A1, SLC46A1 and SLCO1B1 polymorphisms as predictors of methotrexate-related toxicity in Portuguese rheumatoid arthritis patients.

Read more
01 Apr 2014
publication

SLC19A1 80G allele as a biomarker of methotrexate-related gastrointestinal toxicity in Portuguese rheumatoid arthritis patients.

Read more
01 Jan 2014
publication

Role of key TYMS polymorphisms on methotrexate therapeutic outcome in portuguese rheumatoid arthritis patients.

Read more
01 Jan 2014
publication

Prediction of methotrexate clinical response in Portuguese rheumatoid arthritis patients: implication of MTHFR rs1801133 and ATIC rs4673993 polymorphisms.

Read more
01 Jan 2014
publication

Genetic polymorphisms in low-dose methotrexate transporters: current relevance as methotrexate therapeutic outcome biomarkers.

Read more
01 Aug 2013
publication

Current approaches for TYMS polymorphisms and their importance in molecular epidemiology and pharmacogenetics.

Read more